Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure

M Packer, PA Poole-Wilson, PW Armstrong… - Circulation, 1999 - Am Heart Assoc
Background—Angiotensin-converting enzyme (ACE) inhibitors are generally prescribed by
physicians in doses lower than the large doses that have been shown to reduce morbidity …

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study …

M Packer, PA Poole-Wilson, PW Armstrong… - …, 1999 - pubmed.ncbi.nlm.nih.gov
Background Angiotensin-converting enzyme (ACE) inhibitors are generally prescribed by
physicians in doses lower than the large doses that have been shown to reduce morbidity …

Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure

M Packer, PA Poole-Wilson, PW Armstrong… - Circulation, 1999 - cir.nii.ac.jp
< jats: p>< jats: italic> Background</jats: italic>—Angiotensin-converting enzyme (ACE)
inhibitors are generally prescribed by physicians in doses lower than the large doses that …

[引用][C] Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic Heart failure

M PACKER, PA POOLE-WILSON… - … (New York, NY), 1999 - pascal-francis.inist.fr
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor,
lisinopril, on morbidity and mortality in chronic Heart failure CNRS Inist Pascal-Francis CNRS …

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril on morbidity and mortality in chronic heart failure

M Packer, P Poole-Wilson, P Armstrong, J Cleland… - 1999 - hekyll.services.adelaide.edu.au
Background Angiotensin-converting enzyme (ACE) inhibitors are generally prescribed by
physicians in doses lower than the large doses that have been shown to reduce morbidity …

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study …

M Packer, PA Poole-Wilson, PW Armstrong… - Circulation, 1999 - europepmc.org
Background Angiotensin-converting enzyme (ACE) inhibitors are generally prescribed by
physicians in doses lower than the large doses that have been shown to reduce morbidity …

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril on morbidity and mortality in chronic heart failure

M Packer, P Poole-Wilson, P Armstrong, J Cleland… - 1999 - digital.library.adelaide.edu.au
Background Angiotensin-converting enzyme (ACE) inhibitors are generally prescribed by
physicians in doses lower than the large doses that have been shown to reduce morbidity …

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure

M Packer, PA Poole-Wilson… - …, 1999 - utsouthwestern.elsevierpure.com
Background-Angiotensin-converting enzyme (ACE) inhibitors are generally prescribed by
physicians in doses lower than the large doses that have been shown to reduce morbidity …

[引用][C] Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, Lisinopril, on morbidity and mortality in chronic heart failure

M Packer, PA Poole-Wilson, PW Armstrong… - Circulation, 1999 - pure.au.dk
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor,
Lisinopril, on morbidity and mortality in chronic heart failure — Aarhus University Skip to main …

[PDF][PDF] Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure

M Packer, PA Poole-Wilson, PW Armstrong… - 1999 - Citeseer
Background—Angiotensin-converting enzyme (ACE) inhibitors are generally prescribed by
physicians in doses lower than the large doses that have been shown to reduce morbidity …